Navigation Links
DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia

Los Angeles, CA (PRWEB) May 02, 2013

The diabetes drug safety advocates at are announcing new information on the site for those taking the medication Januvia. A recent study suggests the drug may have higher occurrence rates of pancreatitis and pancreatic cancer than traditional pills****.

DrugRisk was created to improve patient safety by providing the latest warnings, recalls, studies and legal news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia is a once-a-day pill introduced in 2006 to help those with type-2 diabetes control blood sugar. It has become Merck’s best-selling drug, with sales of over $4 billion last year*.

However, a 2011 study from UCLA indicated the drug could increase the risk of pancreatic cancer by 272% and thyroid cancer by 148%**. The Journal for the American Medical Association also recently warned Januvia could double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

Now, DrugRisk has added a new study by the Institute for Safe Medication Practices, which found in an analysis of FDA reports that patients were 20.8 times as likely to report pancreatitis or pre-cancerous growth from Januvia than from traditional diabetes treatment like metformin****.

Due to the rising number of patients filing a Januvia lawsuit alleging cancer, lawyers have requested that cases be consolidated to a special federal multi-district court in California. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Januvia is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, Januvia side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit

*Bloomberg News, 2/25/13;
**Gastroenterology, July, 2011;
***Journal of the American Medical Association, 2/25/13;
****Institute for Safe Medication Practices, 4/18/13;

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
2. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
3. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
4. DrugRisk Announces Launch of Byetta Cancer Resource Center
5. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
6. DrugRisk Announces Addition of Januvia Cancer Resource Center
7. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
8. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
9. DrugRisk Announces Launch of DePuy Hip Resource Center
10. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
11. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
Post Your Comments:
(Date:11/29/2015)... Viejo, CA (PRWEB) , ... November 29, 2015 ... ... an all new and unique analog distortion effect tool designed specially for Final ... their footage, and create limiltess looks with the easy-to-use modification controls. Destoying and ...
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... (PRWEB) , ... November 28, 2015 , ... There is ... we outperform our billings from last year? , This question has not been an ... are coming to the retirement age and the younger workforce don’t share the same ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... in America. As people age, more care is needed, especially with Alzheimer’s, dementia ... medical professionals are being overworked. The forgotten part of this equation: 80 percent ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Pays-Bas, November 27, 2015 ... traitement photodynamique au Bremachlorin contre le cancer avancé. ... consistant à combiner l,immunothérapie au traitement photodynamique au ... --> Une nouvelle approche consistant à ... le cancer avancé.    Clinical ...
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology: